Ferring Ventures

• NCT03710876

  Phase 3, Completed, 53 people, Oct 18, 2018

• Secretory products from regulatory macrophages modulate senescence in human endothelial cells: implications for cardiovascular aging and diseases

  Consulting or advice, Mar 31, 2026

Sources: pubmed.ncbi.nlm.nih.gov